Early U.S. Real-World Treatment Patterns and Outcomes in Palopegteriparatide Treatment for Patients With Hypoparathyroidism
This real-world analysis of palopegteriparatide treatment of hypoparathyroidism outside of a clinical trial setting reaffirms its efficacy and safety profile and provides insights into outcomes associated with different treatment transition practices.
Authors
- Lisa Abbott
- Micol S. Rothman (ORCID: https://orcid.org/0000-0002-4577-6801)
- Dolores Shoback (ORCID: https://orcid.org/0000-0003-2936-4468)
- Mark J. Schneider
- Christopher T. Sibley (ORCID: https://orcid.org/0009-0002-7534-7175)
- Jenny Ukena
- Adnan Haider (ORCID: https://orcid.org/0000-0002-2711-2497)
- Natalie E. Cusano (ORCID: https://orcid.org/0000-0003-3042-5336)
- Sara Lubitz (ORCID: https://orcid.org/0000-0002-9514-6744)
- Steven Wai Ing (ORCID: https://orcid.org/0000-0002-4343-6723)
- Mishaela R. Rubin
- Carol Zhao
- Gary W. Edelson
- Timothy E. Graham
Institutions
- Rutgers, The State University of New Jersey (US)
- West Virginia University (US)
- San Francisco VA Medical Center (US)
- University of Nevada, Reno (US)
- Oakland University (US)
- Columbia University Irving Medical Center (US)
- The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US)
- Lenox Hill Hospital (US)
- Johnson University (US)
- The Ohio State University Wexner Medical Center (US)
- West Virginia University Hospitals (US)
- Ascendis Pharma (Denmark) (DK)
- Diabetes & Endocrinology Specialists (US)
- University of Colorado Anschutz Medical Campus (US)
- Columbia University (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- Endocrine Practice
- Published
- 2025-08-21
- DOI
- https://doi.org/10.1016/j.eprac.2025.08.008
- Citations
- 3
- Primary Topic
- Thyroid and Parathyroid Surgery
- Type
- article
- Field-Weighted Citation Impact
- 6.02